Lipophilic Statins and Risk of Hepatocellular Carcinoma and Mortality: A Prospective, Nationwide Population with Chronic Viral Hepatitis

被引:0
|
作者
Simon, Tracey G. [1 ]
Duberg, Ann-Sofi [2 ]
Aleman, Soo [3 ]
Hagstrom, Hannes [4 ]
Chung, Raymond T. [5 ,6 ,7 ]
Ludvigsson, Jonas F. [8 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Orebro Univ Hosp, Orebro, Sweden
[3] Karolinska Univ Hosp, Dept Infect Dis, Solna, Sweden
[4] Karolinska Inst, Div Hepatol, Ctr Digest Dis, Solna, Sweden
[5] Massachusetts Gen Hosp, Ctr Liver, Boston, MA 02114 USA
[6] Massachusetts Gen Hosp, Gastrointestinal Div, Boston, MA 02114 USA
[7] Harvard Med Sch, Boston, MA USA
[8] Karolinska Inst, Med Epidemiol & Biostat, Solna, Sweden
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
93
引用
收藏
页码:59A / 60A
页数:2
相关论文
共 50 条
  • [21] Aspirin Use Mitigates the Risk of Developing Hepatocellular Carcinoma in Patients With Chronic Viral Hepatitis
    Hamid, Osama
    Shah, Aun R.
    Butt, Muhammad U.
    Ghoneim, Sara
    Ali, Rubab
    Asaad, Imad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S511 - S512
  • [22] Viral load as a predictor of mortality from hepatocellular carcinoma and chronic liver disease in chronic hepatitis B infection
    Chen, G
    Lin, WY
    Shen, FM
    Iloeje, UH
    London, WT
    Evans, AA
    JOURNAL OF HEPATOLOGY, 2005, 42 : 173 - 173
  • [23] Metabolic dysfunction-associated fatty liver disease subgroups and risk of hepatocellular carcinoma and mortality in patients with chronic viral hepatitis
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong Gyu
    Ahn, Sang Hoon
    JOURNAL OF HEPATOLOGY, 2022, 77 : S100 - S100
  • [24] STATINS AND THE RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HEPATITIS B VIRUS INFECTION
    Tsan, Y.
    Lee, C.
    Wang, J.
    Chen, P.
    VALUE IN HEALTH, 2012, 15 (07) : A602 - A603
  • [25] Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy
    Tsai, Pei-Chien
    Huang, Chung-Feng
    Yeh, Ming-Lun
    Hsieh, Meng-Hsuan
    Kuo, Hsing-Tao
    Hung, Chao-Hung
    Tseng, Kuo-Chih
    Lai, Hsueh-Chou
    Peng, Cheng-Yuan
    Wang, Jing-Houng
    Chen, Jyh-Jou
    Lee, Pei-Lun
    Chien, Rong-Nan
    Yang, Chi-Chieh
    Lo, Gin-Ho
    Kao, Jia-Horng
    Liu, Chun-Jen
    Liu, Chen-Hua
    Yan, Sheng-Lei
    Lin, Chun-Yen
    Su, Wei-Wen
    Chu, Cheng-Hsin
    Chen, Chih-Jen
    Tung, Shui-Yi
    Tai, Chi-Ming
    Lin, Chih-Wen
    Lo, Ching-Chu
    Cheng, Pin-Nan
    Chiu, Yen-Cheng
    Wang, Chia-Chi
    Cheng, Jin-Shiung
    Tsai, Wei-Lun
    Lin, Han-Chieh
    Huang, Yi-Hsiang
    Chen, Chi-Yi
    Huang, Jee-Fu
    Dai, Chia-Yen
    Chung, Wan-Long
    Bair, Ming-Jong
    Yu, Ming-Lung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (03)
  • [26] Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
    Tsan, Yu-Tse
    Lee, Chang-Hsing
    Wang, Jung-Der
    Chen, Pau-Chung
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (06) : 623 - 630
  • [27] Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
    Tsan, Yu-Tse
    Lee, Chang-Hsing
    Ho, Wen-Chao
    Lin, Meng-Hung
    Wang, Jung-Der
    Chen, Pau-Chung
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (12) : 1514 - 1521
  • [28] Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
    Coskun Ozer Demirtas
    Maurizia Rossana Brunetto
    World Journal of Gastroenterology, 2021, 27 (33) : 5536 - 5554
  • [29] OCCURRENCE OF HEPATOCELLULAR-CARCINOMA IN CHRONIC VIRAL-HEPATITIS
    OMATA, M
    TAKANO, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 33 : S153 - S154
  • [30] Fibrolamellar hepatocellular carcinoma in a patient with chronic viral B hepatitis
    Da Ines, D.
    Lannareix, V.
    Petitcolin, V.
    Bailly, A.
    Charpy, C.
    Abergel, A.
    Chipponi, J.
    Garcier, J. -M.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 (05): : 382 - 386